Christopher Cashman, president and chief executive officer of Marinus Pharmaceuticals recently talked with Rare Disease Report about their drug ganaxolone which the company is developing for…
Thanks! Share it with your friends!
Christopher Cashman, president and chief executive officer of Marinus Pharmaceuticals recently talked with Rare Disease Report about their drug ganaxolone which the company is developing for…
Comments